(TSHA) – Analyst Comments
-
Taysha Gene Therapies (TSHA) PT Raised to $8 at Baird, "very encouraged by the early data"
-
Taysha Gene Therapies (TSHA) PT Raised to $6 at Truist Securities, "data places TSHA as the leader"
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TSHA Stock Lookup